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Epigenetic and epitranscriptomic networks have
important functions in maintaining the pluripotency
of embryonic stem cells (ESCs) and somatic cell re-
programming. However, the mechanisms integrating
the actions of these distinct networks are only
partially understood. Here we show that the chro-
matin-associated zinc finger protein 217 (ZFP217)
coordinates epigenetic and epitranscriptomic regu-
lation. ZFP217 interacts with several epigenetic
regulators, activates the transcription of key pluripo-
tency genes, and modulates N6-methyladenosine
(m6A) deposition on their transcripts by sequestering
the enzyme m6A methyltransferase-like 3 (METTL3).
Consistently, Zfp217 depletion compromises ESC
self-renewal and somatic cell reprogramming, glob-
ally increases m6A RNA levels, and enhances m6A
modification of the Nanog, Sox2, Klf4, and c-Myc
mRNAs, promoting their degradation. ZFP217
binds its own target gene mRNAs, which are also
METTL3 associated, and is enriched at promoters
of m6A-modified transcripts. Collectively, these find-
ings shed light on how a transcription factor can
tightly couple gene transcription to m6A RNA modifi-
cation to ensure ESC identity.
INTRODUCTION
Embryonic stem cell (ESC) self-renewal and somatic cell reprog-
ramming require the precise coordination of transcription fac-
tors, chromatin regulators, and RNA modifiers to be sustained.CellConsiderable efforts have been devoted to characterizing the
epigenetic and transcription networks controlling pluripotency.
However, the function of post-transcriptional RNA modifications
maintaining the equilibrium between ESC self-renewal and dif-
ferentiation remains poorly understood.
Zinc finger protein 217 (Zfp217) encodes a transcription factor
with eight conserved C2H2 zinc finger motifs and a proline-rich
transactivation domain. Overexpression and/or genetic amplifi-
cation of the human homolog ZNF217 correlates with poor
survival in a variety of cancers (reviewed by Quinlan et al.,
2007). Human mammary epithelial cells or ovarian cells trans-
duced with ZNF217 bypass senescence and achieve an immor-
talized state (Li et al., 2007; Nonet et al., 2001), a hallmark of both
cancer and stem cells. Overexpression of ZNF217 provides a se-
lective advantage to tumor cells by deregulating pathways asso-
ciated with normal growth, apoptosis, or differentiation (Huang
et al., 2005; Thollet et al., 2010), in part through INK4B locus
repression (Thillainadesan et al., 2012). ZNF217 has also been
associated with Aurora kinase A overexpression (Thollet et al.,
2010) and with the activation of the transforming growth factor
b (TGF-b) (Vendrell et al., 2012) and AKT pathways (Huang
et al., 2005), required to maintain pluripotency (Boiani and
Scho¨ler, 2005; Lee et al., 2012; Welham et al., 2011). Moreover,
induced differentiation of Ntera2 cells with retinoic acid leads to
downregulation of ZNF217 (Krig et al., 2007). Despite increasing
observations supporting a function of ZNF217 in the mainte-
nance of the undifferentiated state, the role of this transcription
factor in ESC biology remains unexplored.
Recent studies propose that N6-methyladenosine (m6A), the
most abundant post-transcriptional modification in RNA (Jia
et al., 2013; Tuck, 1992), can determine the fate of ESC self-
renewal and pluripotency (Wang et al., 2014b), whereas others
postulate that m6A is required for the transition to differentiated
states (Batista et al., 2014; Geula et al., 2015). The core mamma-
lian methyltransferase complex includes methyltransferase-likeStem Cell 17, 689–704, December 3, 2015 ª2015 Elsevier Inc. 689
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3 (METTL3, also known as MT-A70) and methyltransferase-like
14 (METTL14), which associate with additional regulatory factors
such as Wilm’s tumor 1-associating protein (WTAP) (Liu et al.,
2014; Ping et al., 2014). Enrichment of m6A in RNA effectively
influences all aspects of RNA metabolism, including mRNA sta-
bility (Wang et al., 2014a, 2014b), alternative splicing (Fustin
et al., 2013; Geula et al., 2015; Ping et al., 2014; Zhao et al.,
2014), mRNA translation efficiency (Geula et al., 2015), and sec-
ondary RNA structure and localization, resulting in alterations
in an array of cellular processes. Nonetheless, the molecular
function of m6A RNA modification in development remains
incompletely understood.
In this study, we elucidate the multi-faceted role of ZFP217 in
pluripotency. We show that ZFP217 directly activates the tran-
scription of Nanog, Sox2, and many other genes linked to the
undifferentiated state. Furthermore, ZFP217 restricts the depo-
sition of m6A at these transcripts through METTL3 interaction.
Depletion of Zfp217 results in a decrease in the expression of
pluripotency factors and a global increase of m6A methylation,
promoting the degradation of core stem cell transcripts. Taken
together, these findings demonstrate that ZFP217 is an essential
regulator that balances self-renewal and differentiation not just
by regulating the epigenome but also the epitranscriptome of
pluripotency-associated factors.
RESULTS
Loss of Zfp217 Impairs Self-Renewal and Triggers
Differentiation in ESCs
To explore the function of ZFP217 in ESCs, we analyzed the
expression of Zfp217 in mouse embryonic fibroblasts (MEFs),
ESCs, and induced pluripotent stem cells (iPSCs) by qRT-PCR.
Zfp217 was significantly enriched in ESCs and iPSCs compared
with MEFs (Figure 1A). Examination of Zfp217 expression in ret-
inoic acid (RA)-induced differentiation and in embryoid bodies
(EBs) revealed a gradual decrease in Zfp217 levels, but not
Zfp617, along the course of differentiation, which correlated
with the decrease of Nanog, Pou5f1 (also known as Oct3/4),
and Sox2 (Figures 1B and 1C). In agreement with these findings,
Zfp217 RNA and ZFP217 protein levels were decreased upon
short hairpin RNAs (shRNAs) of the pluripotency factors Nanog,
Pou5f1, and Sox2 (Figures 1D and 1E). Next we conducted loss-
of-function assays by using two distinct shRNAs that exhibited atFigure 1. ZFP217 Is Required to Maintain the Pluripotent State of ESC
(A) qRT-PCR analysis of Zfp217 expression in MEFs, iPSCs, and ESCs. Data are
(B and C) qRT-PCR analysis of Zfp217, Pou5f1, Sox2, and Zfp617 during RA-induc
(n = 3).
(D and E) qRT-PCR analysis of Zfp217 (D) and representative western blot (E)
pluripotency factors was determined to monitor knockdown efficiency. Error bars
b-ACTIN was used as a loading control. Asterisk in (E), nonspecific; Ctrl, control
(F) qRT-PCR (top) and western blot analysis (bottom) to monitor Zfp217 knockdow
For the immunoblot, b-ACTIN was used as a loading control.
(G and H) AP staining of control and Zfp217-depleted ESCs (G). Percentages of
partially differentiated; FD, fully differentiated.
(I) Proliferation rate of control and Zfp217-depleted ESCs relative to shRNA cont
(J) Cell-cycle distribution of control and Zfp217-depleted ESCs examined by DNA
control.
(K) Percentage of early apoptotic cells in control and Zfp217-depleted ESCs de
Error bars show ± SD (n = 3). **p < 0.005, ***p < 0.001 versus control shRNA.
Cellleast 80% knockdown of endogenous ZFP217 protein and
Zfp217 RNA in ESCs (Figure 1F). Although control cells retained
ESC morphology, Zfp217-depleted cells exhibited a flattened
fibroblastic-like morphology typical of differentiating ESCs,
with decreased levels of alkaline phosphatase (AP) staining (Fig-
ure 1G). Specifically, Zfp217 depletion increased the number of
partially and fully differentiated colonies, whereas the number of
undifferentiated colonies decreased drastically (Figure 1H).
Furthermore, loss of Zfp217 resulted in severely compromised
cell growth (Figure 1I), an impaired cell-cycle profile (Figure 1J),
and a marked increase in early apoptosis (Figure 1K). Taken
together, these results suggest that ZFP217 is required to main-
tain the pluripotency state of ESCs.
Somatic Cell Reprogramming Is Impaired upon Zfp217
Knockdown
Given the role of ZFP217 in the maintenance of ESC identity,
we examined ZFP217 function during iPSC reprogramming.
We transduced MEFs by lentiviral infection with a polycistronic
cassette constitutively expressing the Yamanaka factors
(OCT4, SOX2, KLF4, and c-MYC [OSKM]) (Figure 2A; Takahashi
et al., 2007; Takahashi and Yamanaka, 2006), and we observed
upregulation of both Zfp217 andNanog during mouse iPSC gen-
eration (Figures 2B and 2C). Next, the ectopic expression of
OSKMwas combinedwith either control or Zfp217 shRNA, being
the transduction efficiency comparable under both conditions
(Figure S1A). Depletion of Zfp217 in reprogrammable MEFs
markedly reduced the number of AP-positive iPSC colonies,
suggesting that ZFP217 plays a positive role in iPSC generation
(Figures 2D and 2E). Importantly, depletion of Zfp217 did not
affect the proliferation of reprogramming MEFs (Figure 2F), indi-
cating that the decrease in iPSC number is not due to adverse
effects on the proliferative capacity of transduced MEFs. Iso-
lated iPSC clones originated from Zfp217 shRNA-transduced
MEFs were not bona fide iPSCs because they exhibited signifi-
cantly decreased expression of Zfp217 and Nanog relative to
control shRNA (Figures S1B and S1C). A positive role in reprog-
ramming was further supported by ZFP217 overexpression, with
a substantial increase in iPSC colony numbers (Figures 2G–2J).
Reprogramming is a multi-step process initiated by enhanced
proliferation, followed by mesenchymal-to-epithelial transition
(MET) (Li et al., 2010), and completed by activation of pluripo-
tency genes. To identify what stage of reprogramming wass
represented as mean ± SD (n = 3). ***p < 0.0005, **p < 0.005 versus MEFs.
ed differentiation (B) and EB formation (C). Data are represented asmean ± SD
for ZFP217 upon Nanog, Pou5f1, and Sox2 depletion. The expression of the
show ± SD (n = 3). ***p < 0.0001 versus control shRNA. For the immunoblots,
.
n efficiency. Error bars show ± SD (n = 3). ***p < 0.0001 versus control shRNA.
ESC colonies were counted and are depicted in (H). UD, undifferentiated; PD,
rol on day 8. Error bars show ± SD (n = 3). *p = 0.01 versus control shRNA.
content index. Error bars show ± SD (n = 3). Ns, not significant. *p < 0.05 versus
fined as Annexin V-positive and 7-aminoactinomycin D (7AAD)-negative cells.
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blocked upon Zfp217 depletion, we performed immunofluores-
cence microscopy for E-CADHERIN (CDH1), the hallmark of
epithelial cell identity, the stem cell marker stage-specific em-
bryonic antigen 1 (SSEA1), and NANOG on days 5, 10, and 15 af-
ter OSKM reprogramming in the presence of control or Zfp217
shRNA. CDH1 and SSEA1 were activated by day 5 post-infec-
tion, even in the absence of ZFP217 (Figure 2K). Conversely,
NANOG was not activated on day 10 post-transduction, and
its expression remained undetectable on day 15 in reprogram-
ming MEFs depleted of Zfp217 (Figure 2K). Consistently, the
elevation of several pluripotency genes was impaired upon
loss of Zfp217, whereas the expression of most epithelial
and mesenchymal genes analyzed was unaffected in Zfp217-
depleted reprogramming MEFs compared with the control (Fig-
ure 2L; Figures S1D–S1O). Overall, our results indicate that
ZFP217 is required for the generation of iPSCs fromMEFs, being
predominantly indispensable for later stages of somatic cell
reprogramming, when activation of the pluripotency factors
occurs.
ZFP217 Positively Regulates the ESC Transcriptome
To gain an overview of the global role of ZFP217 in pluripotency,
we performed chromatin immunoprecipitation followed by
massively parallel sequencing (ChIP-seq) and RNA sequencing
(RNA-seq) in control and Zfp217 knockdown ESCs. Analysis of
ZFP217 binding identified 10,406 target genes (Table S1) that
were more likely to be regulated upon Zfp217 knockdown
when the binding peak was located at the transcription start
site (TSS) (Figure 3A). Nevertheless, despite the fact that all regu-
lated genes in Zfp217-depleted ESCs were bound by ZFP217,
they represented only a minority of ZFP217 ChIP-seq targets
(Figure 3B) and were not associated with genes important for
ESC identity (data not shown). RNA-seq analysis revealed 882
upregulated genes (Table S1) in Zfp217-depleted ESCs that
associated with gene ontology (GO) categories related to RNA
metabolic processes and transcription (Figure 3C), whereas
the 2,058 downregulated genes upon Zfp217 knockdown (Table
S1) were involved in diverse functions (Figure 3D). Analysis of
peak distribution showed that ZFP217 predominantly occupied
promoters (within 5 kb of the annotated TSS) and intergenic
regions of actively transcribed and bivalent genes (Figures 3E–
3G; Figures S2A–S2C). Because human ZNF217 is associated
with the corepressor for element 1-silencing transcription factor
(CoREST) (Cowger et al., 2007; Lee et al., 2005; You et al., 2001),
we examined the overlap between ZFP217 and the previously
published REST cofactors (SIN3A/B) and CoREST complexFigure 2. ZFP217 Is Required for Somatic Cell Reprogramming
(A) Schematics of iPSC generation. d, day; IF, immunofluorescence.
(B and C) Representative qRT-PCR analysis for Zfp217 (B) and Nanog (C) during
(D and E) AP staining (D) and quantification (E) of control and Zfp217-depleted iPS
(F) Proliferation rate of control and Zfp217-depleted reprogramming MEFs.
(G) AP staining of reprogramming MEFs overexpressing ZFP217_HA or empty v
(H and I) Number of AP+ (H) and GFP+ (I) colonies in ZFP217_HA relative to emp
(J) Proliferation rate of reprogramming MEFs transduced with ZFP217_HA or em
(K) E-CADHERIN (CDH1), SSEA1, andNANOG immunostaining on the indicated d
at the right. Scale bars, 100 mm.
(L) Heatmap illustrating the relative expression of pluripotency, epithelial, and me
or Zfp217 shRNA on the indicated days.
Cell(RCOR1, RCOR2, and RCOR3) datasets. Our analysis revealed
that the vast majority of genes occupied by some of the CoREST
members were enriched with ZFP217 (Figure S2D). In accor-
dance with the fact that the CoREST complex is implicated
in neuronal differentiation (Yu et al., 2011), the ZFP217-bound
bivalent genes functioned in commitment to the neural lineage
(Figure S2E).
Next, we performed de novomotif analysis using the algorithm
multiple EM for motif elicitation (MEME) and identified a unique
DNA motif enriched at ZFP217 sites (Figure 3H) that overlapped
with the binding sequence for STAT3 (Figure 3I). Secondary mo-
tifs overrepresented in ZFP217-bound regions included known
binding sequences for KLF4, SP1, and POU5F1 (Figure 3I),
among others, suggesting that ZFP217 might occupy an over-
lapping set of genomic sites important for the regulation of the
undifferentiated state. In agreement with this observation, in-
spection of individual gene tracks of ZFP217 and publicly avail-
able POU5F1 datasets showed ZFP217 and POU5F1 binding at
the core promoter and at the enhancers of Pou5f1, Nanog, and
Sox2 (Figures S3A–S3C). Moreover, RNA-seq profiling revealed
a significant decrease of key ESC transcripts upon Zfp217
depletion (Figures 4A and 4B), suggesting an important role for
ZFP217 in regulating the expression of stem cell identity genes.
Further expression analysis revealed that levels of ectodermal
and endodermal markers, but not trophectodermal and meso-
dermal markers, were increased in Zfp217 knockdown ESCs
(Figures S3D–S3G), suggesting that the repressor activity of
ZFP217 on developmental genes is also important for ESCmain-
tenance. To further determine whether ZFP217 directly regulates
the expression of genes encoding the core pluripotency factors,
we cloned the well characterized Nanog, Pou5f1, and Sox2 en-
hancers into the Oct4 minimal promoter and transfected these
reporters into either control or Zfp217-depleted ESCs. A signifi-
cant decrease in luciferase activity upon Zfp217 knockdown
suggested a direct regulation (Figure 4C), which was further
validated by ChIP-qPCR of ZFP217 (Figure 4D). Because lysine
demethylase 1 (LSD1), a known interacting partner of ZFP217
involved in enhancer decommissioning of pluripotency genes
(Whyte et al., 2012), also bound these genomic regions (Fig-
ure 4D; Figures S3A–S3C), we reasoned that the overlap of
ZFP217, LSD1, and POU5F1 genome-wide binding might reveal
the occupancy of the stem cell identity genes. Indeed, ZFP217,
LSD1, and POU5F1 co-occupied hundreds of sites in the ESC
genome (Figure S3H), which was supported by heatmap clus-
tering of the read density, where an enriched signal was preva-
lent surrounding the center of ZFP217 binding sites (Figure 4E).MEF reprogramming.
Cs on day 21. Error bars show ± SD (n = 3). ***p < 0.0001 versus control shRNA.
ector on day 15 post-transduction.
ty vector. Error bars show ± SD (n = 3). **p < 0.001 versus empty vector (EV).
pty vector.
ays of reprogramming with control orZfp217 shRNA. The bright field is depicted
senchymal genes measured by qRT-PCR in reprogramming MEFs with control
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Nevertheless, additional elements must be required for
this association because co-immunoprecipitation experiments
showed interaction between ZFP217 and LSD1 but not with
POU5F1 (Figure S3I). Expectedly, ZFP217-LSD1-POU5F1 target
genes were enriched in undifferentiated cells compared with
RA-induced differentiated cells (Table S2) or EBs (Figure 4F,
top) and were associated with an ESC identity signature (Fig-
ure 4F, bottom). Accordingly, ZFP217 localized at superen-
hancers, identified at genes important for the maintenance of
pluripotency (Figure S3J; Whyte et al., 2013). Overall, our find-
ings indicate that ZFP217 globally contributes to the transcrip-
tional program that maintains the expression of core stem cell
genes to preserve ESC self-renewal.
ZFP217 Interacts with METTL3 and Negatively Affects
m6A Deposition
To gain insight into the molecular mechanism by which ZFP217
controls ESC maintenance and somatic cell reprogramming, we
performed immunoprecipitation experiments with endogenous
ZFP217 in ESCs, followed by liquid chromatography-tandem
mass spectrometry (LC-MS/MS). We identified ZFP217 as well
as peptides representative of LSD1, RCOR1, RCOR2, C-termi-
nal-binding proteins 1 (CTBP1) and 2 (CTBP2), and histone
deacetylase 1 (HDAC1), consistent with previously reported
binding partners of ZNF217, and, therefore, validating our
approach (Banck et al., 2009; Cowger et al., 2007; Quinlan
et al., 2006; You et al., 2001; Figure 5A; Table S3). Interestingly,
we also identified numerous proteins involved in RNA post-tran-
scriptional modification, including mRNA and rRNA processing,
rRNA maturation and splicing, and methylation, among others
(Figure 5B).
We focused our attention on the interaction of ZFP217 with
the RNA methyltransferase METTL3 because the regulation
and function of m6A mRNA in ESCs remains largely unknown.
Although ZFP217 has not been identified as a METTL3-interact-
ing protein in recent studies (Liu et al., 2014; Schwartz et al.,
2014), we could verify a robust and specific association between
ZFP217 and METTL3 in ESCs by co-immunoprecipitation (Fig-
ure 5C, left) and reverse coIP experiments of the endogenous
proteins (Figure 5C, right). Consistent with the fact that METTL14
was not present in our LC-MS/MS analysis, we could not detect
METTL14 after ZFP217 immunoprecipitation (Figure 5C, bot-
tom), suggesting that METTL3 could be part of multiple dynamic
complexes. Notably, ZFP217-METTL3 association was DNA-
and RNA-independent (Figure 5D) because treatment of the
nuclear extracts with DNase I or RNase A did not interfere with
the precipitation of METTL3 with anti-ZFP217 antibodies.Figure 3. ZFP217 Is Associated with Both Promoters and Enhancers in
(A) The relative position of the unique closest ZFP217 peaks with respect to the T
depletion (y axis).
(B) The number of ZFP217-only-bound genes, activated and bound, and repress
(C and D) Functional categories of genes activated and bound (C) and represse
enrichment of biological process GO term.
(E) The distribution of ZFP217-binding peaks relative to the nearest TSS.
(F) The genomic distribution of ZFP217-binding peaks, including promoters (within
introns, exons, upstream (within 10 kb upstream of the gene), and intergenic reg
(G) ZFP217 binding sites (black lines) at active (green), bivalent (dark green), and
(H and I) ZFP217 de novo motif (H) and ZFP217 binding at known binding motifs
CellMettl3 expression was markedly enriched in ESCs and iPSCs
comparedwithMEFs (Figure 5E). Accordingly,Mettl3mRNA and
the mRNA of other members of the m6A methyltransferase com-
plex were decreased significantly upon RA- and EB-induced
ESC differentiation (Figures 5F and 5G; Figure S4A). However,
Mettl3-depleted ESCs maintained an undifferentiated state
with high AP activity and no significant changes in core stem
cell factor expression (Figures S4B–S4D), suggesting that
METTL3 is dispensable for ESC self-renewal and may be
involved in other aspects of stem cell biology, as proposed pre-
viously (Batista et al., 2014). Because Mettl3 RNA and METTL3
protein levels were unchanged upon Zfp217 knockdown (Fig-
ure S4E), we sought to analyze whether ZFP217 was affecting
METTL3 m6A activity in vivo. Therefore, we analyzed m6A
methylation levels in control and Zfp217-depleted ESCs by using
three independent methods: m6A immunostaining, dot blot, and
LC-MS/MSquantification of them6A/A ratios in purified polyade-
nylated (poly(A)+) RNA. Our analysis revealed a global increase of
m6A levels in Zfp217-depleted cells compared with the control
(Figures 5H–5J; Figures S4F–S4H), whereas m6A levels were
decreased drastically upon Mettl3 knockdown (Figure 5H; Fig-
ure S4I). Taken together, our data suggest that ZFP217 interacts
with METTL3 to prevent cellular m6A RNA deposition.
Analysis of m6A Methylome in ESCs Depleted of Zfp217
To elucidate the mechanism by which ZFP217 regulates m6A
restriction, we analyzed m6A RNA methylation in control and
Zfp217-depleted ESCs throughmethylated RNA immunoprecip-
itation sequencing (MeRIP-seq) (Table S4). Comparison be-
tween the two conditions revealed an increase of m6A sites
across 3,586 RNAs upon Zfp217 knockdown (Figure 6A). Hence-
forth, we will refer to these transcripts as the ZFP217-dependent
sites. ZFP217-dependent RNAs spanned a wide set of functions
(Figure 6B) that were enriched in the undifferentiated state, as
assessed by gene set enrichment analysis (GSEA) (Figure 6C).
Next, we overlapped ZFP217-dependent sites with published
available MeRIP-seq datasets ofMettl3 knockout ESCs (Batista
et al., 2014). The vast majority of the common peaks (72%)
experienced a decrease in m6A methylation levels upon Mettl3
knockout and an increase in m6A RNA modification after
Zfp217 depletion, suggesting that ZFP217 is antagonizing the
RNA methyltransferase activity of METTL3 (Figure 6D). Interest-
ingly, 25% of common peaks underwent an increase in m6A
levels in Zfp217- and Mettl3-depleted cells, whereas just 3%
of them had a decrease in methylation under both conditions.
Methylated m6A sites from control and Zfp217-depleted cells
were located within a median distance of 30 nt from the nearestESCs
SS (x axis) and the log2 fold change in gene expression in response to Zfp217
ed and bound in Zfp217-depleted ESCs.
d and bound (D) upon Zfp217 depletion of ESCs showing the p value for the
5 kb upstream of the TSS), downstream (within 10 kb downstream of the gene),
ions.
silent (orange) genes (defined in the Supplemental Experimental Procedures).
for STAT3, KLF4, SP1, and POU5F1 (I) with the corresponding p values.
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consensus RRACU sequence motif (Figures 6E–6F; Meyer and
Jaffrey, 2014). As described previously (Dominissini et al.,
2012; Meyer et al., 2012), m6A sites were enriched significantly
near the stop codon and the beginning of the 30 UTR, with virtu-
ally no peaks located at the TSS of the protein-coding genes
(Figure S5A). The m6A enrichment was positively correlated
with exon length, with median internal exons harboring sites in
Zfp217 shRNA ESCs longer than in control shRNA (Figure S5B).
To test whether the global increase in m6A levels was a conse-
quence of increased transcription upon Zfp217 knockdown,
we analyzed the expression of transcripts harboring m6A modi-
fication in control and Zfp217-depleted ESCs. Our analysis re-
vealed that these transcripts were not differentially enriched
upon Zfp217 knockdown (Figure S5C), providing strong evi-
dence that ZFP217 modulates m6A RNA levels by counteracting
METTL3 activity.
Because ZFP217 was associated with a large number of RNA
binding proteins (RBPs), we sought to test the RNA binding ca-
pacity of ZFP217 per se. We performed RNA immunoprecipita-
tion coupled with sequencing (RIP-seq) for ZFP217 andMETTL3
and identified 5,933 and 6,971 RNAs associated with ZFP217
and METTL3 (Table S5), respectively. The vast majority of
ZFP217-bound transcripts notably overlapped with the METTL3
transcriptome (Figure 6G) and was mainly composed of mRNAs
associated with transcription and regulation of transcription (Fig-
ures S5D–S5F). To further explore a connection between the
epigenome and the epitranscriptome, we generated enrichment
profiles around the genomic region of ZFP217 target genes with
ChIP-seq and RIP-seq datasets for ZFP217. ZFP217 occupancy
at promoters of genes encoding ZFP217-associated transcripts
was higher than in non-associated transcripts (Figure 6H; Fig-
ure S5G). Moreover, RNAs harboring m6A modification experi-
enced higher ZFP217 binding, but not POU5F1 binding, at the
TSS compared with transcripts that lacked m6A modification
(Figure 6I; Figure S5H). Collectively, these findings indicate that
ZFP217 tightly coupled epigenetic regulation and m6A RNA
modification. The observation that RNA polymerase II (Pol II)
occupancy was enriched in modified transcripts (Figure S5I)
suggests that m6A deposition might occur in parallel with tran-
scription, although further validation is required.
ZFP217 Regulates the Epitranscriptome of Key
Pluripotency Factors Affecting Somatic Cell
Reprogramming
To further integrate the global mechanism by which ZFP217
regulates the ESC state, we merged the ZFP217 ChIP-seq da-Figure 4. ZFP217 Positively Regulates the ESC Transcriptome
(A) Scatterplot of upregulated and downregulated genes in control compared wi
(B) qRT-PCR analysis of pluripotency-associated genes in ESCs transduced wit
(n = 3). *p < 0.0001 versus control shRNA.
(C) Luciferase assay of the indicated constructs transfected in control orZfp217-d
and represented relative to the minimal Oct4 promoter. Error bars show ± SD (n
(D) ChIP-qPCR analysis of ZFP217 (top), LSD1 (center), and POU5F1 (bottom) bin
are indicated in Figures S3A–S3C. E1 and E2, enhancer 1 and enhancer 2, resp
immunoglobulin G (IgG) control.
(E) Density maps of ZFP217, LSD1, and POU5F1 ChIP-seq datasets at the TSS.
(F) GSEA plots of ZFP217, LSD1, and POU5F1-bound genes during RA-induce
represented in red and blue, respectively. Bottom: functional categories of ZFP
annotations tool (GREAT) software. NES, normalized enrichment score; FDR, fal
Celltaset with m6A ZFP217-dependent transcripts and ZFP217 and
METTL3 transcriptomes (Figure 7A). We identified the core plu-
ripotency factors Nanog, Sox2 (Figures S6A and S6B), Klf4,
and c-Myc and other factors with a reported function in ESC
maintenance (Table S6). Interestingly, Wtap, one of the core
components of the m6A methyltransferase complex, and the
‘‘readers’’ Ythdf2 and Ythdf3 were also detected in this group,
indicating that ZFP217 might play an active role not just in
modulating m6A deposition but also in modulating the clear-
ance of this RNA modification. To assess the robustness
and reproducibility of our analysis, we performed photoac-
tivatable-ribonucleoside-enhanced crosslinking and immuno-
precipitation (PAR-CLIP) with ZFP217 antibodies following
qRT-PCR. We detected binding of ZFP217 at pluripotency
transcripts (Figure 7B) but not at U1, which was used as a
negative control. Moreover, MeRIP revealed an increase of
m6A modification at these transcripts upon Zfp217 knockdown
(Figure 7C; Figures S6C–S6D), which was associated with a
decrease in the lifetime of the Nanog, Sox2, c-Myc, and Klf4
mRNAs (Figures 7D–7G), whereas the stability of the non-target
transcripts Stat3 and U1 was unaffected (Figure 7H; Fig-
ure S6E). Given that the catalytic domain of METTL3 is also
involved in RNA recognition (Bujnicki et al., 2002), we sought
to analyze whether ZFP217 was affecting METTL3 binding to
RNA and, therefore, its m6A methyltransferase activity by per-
forming PAR-CLIP with METTL3 antibodies in control and
Zfp217-depleted ESCs. The amount of RNA associated with
endogenous METTL3 was increased significantly after loss of
Zfp217 (Figure 7I; Figure S6F), suggesting that ZFP217 seques-
ters METTL3 into an inactive complex.
Because loss of Zfp217 led to an increase in global m6A levels
in reprogramming MEFs (Figure S6G), we asked whether
concomitant depletion of Mettl3 was sufficient to rescue the
impairment of iPSC reprogramming after Zfp217 knockdown.
Consistent with the fact that METTL3 is dispensable for inner
cell mass (ICM) naive pluripotency established in vivo (Geula
et al., 2015), depletion of Mettl3 in reprogrammable MEFs did
not decrease the number of AP-positive iPSC colonies (data
not shown). Importantly, depletion of Mettl3 partially rescued
iPSC reprogramming in Zfp217-depleted cells (Figures 7J and
7K; Figure S6H), suggesting that the increment of m6A levels
occurring upon Zfp217 knockdown is also a barrier for efficient
somatic cell reprogramming.
Collectively, our results show that ZFP217 is required to pre-
vent aberrant methylation of the core pluripotency and reprog-
ramming factors, inhibiting ESC differentiation and promotingth Zfp217-depleted ESCs.
h Zfp217_1 or Zfp217_2 compared with control shRNA. Error bars show ± SD
epleted ESCs. Data are normalized to cytomegalovirus (CMV)-Renilla luciferase
= 3). **p < 0.001; *p < 0.05; ns = not significant versus control shRNA.
ding at the Pou5f1,Nanog, and Sox2 loci. The positions of the amplified regions
ectively. Error bars show ± SD (n = 3). *p < 0.0001; ns, not significant versus
The color scale indicates the ChIP-seq signal in reads per million.
d differentiation and EB formation. Top: high and low expression of genes is
217, LSD1, and POU5F1-bound genes using genomic regions enrichment of
se discovery rate
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efficient iPSC reprogramming. We propose a model in which
ZFP217 regulates stem cell maintenance and self-renewal by
different mechanisms that are not mutually exclusive and can in-
fluence each other (Figure 7L). That is, ZFP217 directly regulates
transcription of key pluripotency and reprogramming genes,
including Nanog, Sox2, Klf4, and c-Myc, and promotes their
stabilization by preventing METTL3-mediated m6A aberrant
methylation.
DISCUSSION
Function of ZFP217 in ESC Self-Renewal and Somatic
Cell Reprogramming
ESCs represent an invaluable resource to investigate human dis-
ease. However, in-depth understanding of the epigenetic and
epitranscriptomic mechanisms controlling self-renewal, pluripo-
tency, and transitions to differentiated cell fates is necessary for
ESCs to hold great promise for regenerative medicine. Here we
conducted detailed multidisciplinary research to characterize
the role of ZFP217 in ESCs, and we identified ZFP217 to be
essential for maintaining the undifferentiated state by tightly
coupling epigenetic regulation and m6A RNA modification.
The high Zfp217 expression levels in ESCs and during iPSC
reprogramming is a consequence of the direct regulation
of ZFP217 by the pluripotency factors NANOG, POU5F1, and
SOX2. In addition, we observed severely impaired pluripotency
through the downregulation ofNanog, Pou5f1, and Sox2 expres-
sion in ESCs depleted of Zfp217, suggesting that ZFP217 is
essential in the control of early embryogenesis and that it may
operate within an autoactivating feedback loop. Moreover,
our results show that depletion of Zfp217 in ESCs results in
cell proliferation defects by triggering cell-cycle arrest and
apoptosis, which further shifts the self-renewal phenotype
toward differentiation.
In this study, we also illustrate the role of ZFP217 in late stages
of somatic cell reprogramming, when pluripotency factors are
activated. Zfp217 depletion significantly decreases both the
number of iPSCs and the efficiency of reprogramming, which
is in part due to m6A hypermethylation. Three of four of the
Yamanaka factors undergo an increase in m6A of mRNAs upon
Zfp217 knockdown, affecting their half-life and the reprogram-
ming capacity. In fact, concurrent depletion of both Zfp217
and Mettl3 is sufficient to partially rescue the impairment of
iPSC reprogramming upon Zfp217 loss. These observationsFigure 5. ZFP217 Interacts with METTL3 and Counteracts Its Activity
(A) The network of associated proteins identified through LC-MS/MS of ZFP217
(B) Ingenuity pathway analysis (IPA) of proteins identified with LC-MS/MS. Left: th
transcriptional modification category.
(C) Immunoprecipitation of nuclear extracts from ESCs with antibodies against Z
METTL3, and METTL14 antibodies. IgG was used as a control.
(D) Immunoprecipitation (IP) of nuclear extracts pretreated with DNase I or RNas
and METTL3 antibodies. IgG was used as a control.
(E) qRT-PCR analysis of Mettl3 expression in MEFs, iPSCs, and ESCs. Error bar
(F and G) RT-qPCR analysis of Mettl3 during RA-induced differentiation (F) and E
(H) m6A immunostaining of ESCs transduced with control, Zfp217_1, or Mettl3_1
(I) Dot blot analysis of polyadenylated RNA (poly(A)+) isolated from control and Z
m6A antibody. Methylene blue staining was used as a loading control.
(J) LC-MS/MS quantification of the m6A/A ratio in polyadenylated RNA isolated
*p < 0.05 versus control shRNA.
Cellcould position themodulation ofZfp217 expression as a valuable
tool for approaching stem cell therapies.
Comprehensive Roles for ZFP217 within an Integrated
Epigenetic Regulatory Model
Given the broad number of binding regions identified by ZFP217
ChIP-seq, ZFP217 promoter occupancy is not correlated with
changes in gene expression. What is the molecular basis for
this promiscuous recruitment in ESCs? ZFP217 DNA-binding
activity for specific and non-specific sequences is similar, with
the exchange rate between the free and bound protein being
faster for the nonspecific complex (Vandevenne et al., 2013).
Therefore, ZFP217 would open genomic DNAwith its DNA-bind-
ing surface, recruiting additional proteins at such sites and,
therefore, facilitating the targeting of sequence-specific DNA
binding sites among a region of non-specific sites.
Overall, we made different observations in our comprehen-
sive and integrative epigenomic analysis. First, ZFP217 occu-
pancy is highly enriched at TSSs, overlapping with RNA Pol II
Ser-5P, suggesting that ZFP217 could be involved in pro-
moter-proximal pausing in ESCs, thereby facilitating co-tran-
scriptional alternative splicing. Indeed, ZFP217 was found
to interact with several RBPs involved in most aspects of
RNA metabolism, including RNA processing, maturation, and
splicing. Second, ZFP217 occupies actively transcribed genes,
and, to a lesser extent, ZFP217 can also be located at poised or
bivalent promoters of neuroectodermal genes. Third, enhancer
and promoter regions of stem cell identity genes are co-occu-
pied by ZFP217, LSD1, and POU5F1. Studies published previ-
ously have shown interaction between LSD1 and ZNF217,
where ZNF217 is important for LSD1 recruitment at specific
genomic locus (Thillainadesan et al., 2012). On the other hand,
most of the POU5F1-associated proteins are transcriptional re-
pressors (Liang et al., 2008) that were also found in different re-
ported ZNF217 interactome analyses, suggesting that these
proteins could be part of the same transcriptional complex.
Ultimately, our work indicates that ZFP217 is required for direct
transcriptional activation of the core pluripotency factors. Given
that ZFP217 is a bifunctional transcription factor, it is likely
that negative regulation of gene expression through ZFP217 is
equally important to maintain pluripotency. Understanding the
relative contributions of activation and repression could provide
fundamental insights regarding the dynamic control of stem-
ness mediated by ZFP217.. Black and red lines represent published and novel interactions, respectively.
e molecular and cellular functions. Right: function annotations of the RNA post-
FP217 (left) or METTL3 (right), followed by immunoblotting (IB) with ZFP217,
e A with antibodies against ZFP217, followed by immunoblotting with ZFP217
s show ± SD (n = 3). ***p < 0.0005 versus MEFs.
B formation (G). Error bars show ± SD (n = 3).
shRNAs. Nuclei were stained with DAPI. Scale bars, 100 mm.
fp217_1 shRNA ESCs. The indicated amounts were loaded and detected with
from control and Zfp217_1 knockdown ESCs. Error bars show ± SD (n = 2).
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(B) Functional categories of ZFP217-dependent m6A sites. The p value for the enrichment of biological process GO-term is shown.
(C) GSEA plot of ZFP217-dependent m6A sites during RA-induced differentiation (top) and EB formation (bottom). High and low expression of genes is repre-
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(D) Heatmap representing log2 fold change ofZfp217 shRNAESCs comparedwith control (left) andMettl3 knockout (KO) ESCs comparedwith theWT (right). Red
and blue indicate an increase and decrease of m6A peak intensity, respectively.
(E) Distributions of distance between the m6A peak and the nearest consensus site of control and Zfp217-depleted ESCs.
(F) Sequence logo representing the consensus motif following clustering of all enriched motifs in ZFP217-dependent peaks.
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ZFP217 in Regulating N6-Methyladenosine mRNA
Methylation
Because METTL3 is a member of the m6A methyltransferase
complex that has not yet been characterized, our intent was
to resolve the ZFP217-METTL3 interaction with our LC-MS/
MS analysis. Importantly, the role of METTL3 in ESCs has
only been investigated recently. One model proposes that
m6A methylation on developmental regulators blocks HuR bind-
ing and destabilizes such transcripts, thereby maintaining plu-
ripotency (Wang et al., 2014b). Other studies postulate that
m6A is not required for ESC maintenance but for transition of
ESCs to differentiated lineages (Batista et al., 2014). In agree-
ment with the latter observation, Mettl3 knockout epiblasts
and naive ESCs are viable at the pre-implantation stage. How-
ever, they are unable to exit the naive state at the post-implan-
tation period, leading to embryonic lethality (Geula et al., 2015).
ZFP217 has crucial regulatory functions in m6A deposition,
adding a layer of complexity to our understanding of the molec-
ular events regulating RNA methylation in ESCs. ZFP217
sequesters METTL3, diminishing METTL3 binding to RNAs.
Moreover, the fact that ZFP217 does not interact with METTL4
strongly suggests that METTL3-ZFP217 is held in an inactive
complex. How do the cells dynamically control m6A RNA modi-
fication in ESCs? Conceptually, we propose that, in the undif-
ferentiated state, high levels of METTL3 methyltransferase
activity are tightly regulated by ZFP217, preventing core ESC
transcripts from aberrant methylation. During cell differentia-
tion, expression of ZFP217 and its target genes decreases
rapidly. METTL3 is free and catalyzes m6A methylation at the
few pluripotency transcripts that still remain, a requirement to
exit the pluripotency state. ZFP217 occupancy at promoters
of genes encoding ZFP217-bound transcripts and m6A-methyl-
ated RNAs is higher than at unbound and unmodified tran-
scripts, strongly suggesting that ZFP217 controls different
regulatory layers of pluripotency, possibly in a redundant and
overlapping manner. Therefore, it is reasonable to think that
epigenetic mechanisms may impose the composition of the
stem cell epitranscriptome.
In summary, we demonstrate that ZFP217 is critical for the
maintenance of ESC self-renewal and somatic cell reprogram-
ming by regulating the transcription of pluripotency genes and
preventing such transcripts from aberrant m6A methylation.
The direct connection between ZFP217 and m6A methylation
in maintaining and reacquiring a pluripotent state providesFigure 7. ZFP217 Regulates the Epitranscriptome of Key Pluripotency
(A) ZFP217 ChIP-seq target genes, m6A ZFP217-dependent transcripts, and ZFP
(B) qRT-PCR ofNanog,Sox2,Klf4, and c-Myc after PAR-CLIPwith ZFP217-specifi
show ± SD (n = 3). **p < 0.01, ***p < 0.001 versus IgG control.
(C) qRT-PCR of m6A modification at key pluripotency RNAs in control and Zfp2
***p < 0.0001; ns, not significant versus control shRNA.
(D–H) qRT-PCR analysis of Nanog (D), Sox2 (E), Klf4 (F), c-Myc (G), and Stat 3 (
Zfp217-depleted ESCs. Error bars show ± SD (n = 2). ***p < 0.0001; **p < 0.001;
(I) Quantification of the RNA binding ability of METTL3 in control and Zfp217-deple
pull-down proteins. Error bars show ± SD (n = 2). *p < 0.005 versus control shRN
(J and K) AP staining of reprogrammingMEFs transducedwith OSKM in the presen
relative to control iPSCs (K). Error bars show ± SD (n = 4). ***p < 0.0001 versus Z
(L) ZFP217 function in ESC self-renewal and iPSC reprogramming. In our mo
programming factors, including Nanog, Sox2, Klf4, and c-Myc, and promotes
methylation.
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tion network in stem cell biology. Given the emerging promi-
nence of ZNF217 in oncogenesis (Collins et al., 1998; Little-
page et al., 2012), we suggest that m6A modification is
relevant in human cancers. Dissecting the molecular mecha-
nisms that mediate these methylation changes in RNA could
predict cancer risk, achieve early diagnosis, track the prog-
nosis of tumor fate, and, ultimately, provide novel therapeutic
approaches.
EXPERIMENTAL PROCEDURES
For full details, see the Supplemental Experimental Procedures.
Cell Culture and Differentiation Assays
CCE murine ESCs were grown under typical feeder-free ESC culture
conditions. To induce differentiation with RA, leukemia inhibitory factor (LIF)
(eBioscience) was removed, and RA (Sigma-Aldrich) was added at a concen-
tration of 5 mM. EBs were obtained by growing ESCs in low-attachment dishes
in the presence of complete medium and without LIF.
Somatic Cell Reprogramming
Early passage MEFs were infected with a single lentiviral stem cell cassette
(STEMCCA) constitutively expressing all four Yamanaka factors. The day after
infection, MEFs were replated at a density of 50,000 cells/well on irradiated
MEF feeder layers and cultured in mouse iPSC medium.
ChIP Assays
ChIP was performed as described previously (Whyte et al., 2012). The
following antibodies were used: anti-ZNF217 (Santa Cruz Biotechnology,
catalog no. sc 55351x), anti-OCT3/4 (Santa Cruz, catalog no. sc-8628), and
anti-LSD1 (Abcam, catalog no. ab17721).
Analysis of m6A Levels
RNA m6A levels were determined by dot blot, m6A immunostaining, and LC-
MS/MS as described in the Supplemental Experimental Procedures. m6A
MeRIP-seq was conducted as described previously (Dominissini et al., 2012).
PAR-CLIP
CCE cells were incubated with 200 mM of 4-thiouridine (4SU) (Sigma Aldrich)
for 14 hr and crosslinked with 0.4 J/cm2 at 365 nm. After lysis, immunopre-
cipitation was carried out with ZFP217 or METTL3 antibodies (5 and 3 mg,
respectively) overnight at 4C. Precipitated RNA was labeled with [g-32-P]-
ATP and visualized by autoradiography. For PAR-CLIP qRT-PCR analysis,
proteins were removed with Proteinase K digestion, RNA was extracted
using Trizol and the RNeasy mini kit (QIAGEN), and RNA was reverse-
transcribed with the SuperScript VILO cDNA synthesis kit. qRT-PCR anal-
ysis of the retrotranscribed RNA was performed with specific primers as
indicated.Factors
217 and METTL3 transcriptomes.
c antibodies. Shown is the fold enrichment relative to the IgG control. Error bars
17 shRNA. The percentage of input is shown. Error bars show ± SD (n = 3).
H) expression after 8 hr of 5-ethynyl uridine (EU) incorporation in control and
*p < 0.01; ns, not significant versus control shRNA at 8 hr.
ted ESCs (from Figure S6E). RNA binding was normalized to the corresponding
A.
ce of the indicated shRNA constructs on day 15 (J) and number of AP+ colonies
fp217 shRNA.
del, ZFP217 directly regulates the transcription of key pluripotency and re-
their stabilization by preventing them from METTL3-mediated m6A aberrant
c.
Statistical Analysis
All valueswere expressed asmean ± SD. Statistical analysis was performed by
unpaired Student’s t test. A p value of less than 0.05 was considered statisti-
cally significant.
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